Cancer Res Treat.
2025 Jan;57(1):289-290. 10.4143/crt.2024.779.
Commentary on “Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma”
- Affiliations
-
- 1Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey
- 2Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey
- 3Department of Radiation Oncology, Koc University School of Medicine, Istanbul, Turkey
- 4Department of Radiation Oncology, Koc University School of Medicine, Istanbul, Turkey
- KMID: 2564601
- DOI: http://doi.org/10.4143/crt.2024.779
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Reply to Commentary on “Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma”
- Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
- Less is more: role of additional chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal cancer management
- Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy
- Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
